Related Experiment Video
Updated: May 15, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation
S Shabbeer1, D Omer, D Berneman
11] Department of Human Science, SNHS, Georgetown University Medical Center, Washington, DC, USA [2] Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Abstract:
The BRCA1 tumor suppressor protein heterodimerizes with its partner protein, BARD1, via the RING domain present in both proteins. The heterodimer contains an E3 ubiquitin ligase activity and participates in multiple cellular functions such as cell cycle control, DNA repair and regulation of gene transcription, collectively aimed at maintaining genomic stability and tumor suppression. Yet, the precise role of BRCA1 E3 ligase in these cellular functions is poorly understood. We present data showing that BRCA1 ubiquitinates G2/M cell cycle proteins, cyclin B and Cdc25C, leading to their accelerated degradation via a mechanism that is independent of APC/C. BRCA1-dependent degradation of cyclin B and Cdc25C is reversed by proteasome inhibitors and is enhanced following DNA damage, which may represent a possible mechanism to prevent cyclin B and Cdc25C accumulation, a requirement for mitotic entry. Our data provide mechanistic insight into how BRCA1 E3 ligase activity regulates the G2/M cell cycle checkpoint and, thus, contributes to maintenance of genomic stability.
Insights
The BRCA1 tumor suppressor protein targets cell cycle proteins cyclin B and Cdc25C for degradation, independent of APC/C. This BRCA1 E3 ligase activity helps maintain genomic stability by regulating the G2/M cell cycle checkpoint.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The BRCA1 tumor suppressor protein forms a heterodimer with BARD1, possessing E3 ubiquitin ligase activity.
- This complex is crucial for DNA repair, cell cycle control, and gene transcription, collectively maintaining genomic stability and suppressing tumors.
- The exact role of BRCA1's E3 ligase activity in these cellular processes remains unclear.
Purpose of the Study:
- To elucidate the specific role of BRCA1 E3 ligase activity in regulating cell cycle progression.
- To investigate the mechanism by which BRCA1 influences key cell cycle proteins.
- To understand how BRCA1 contributes to genomic stability through its ligase function.
Main Methods:
- Investigated BRCA1 ubiquitination of G2/M cell cycle proteins, cyclin B and Cdc25C.
- Assessed the degradation pathways of cyclin B and Cdc25C in a manner independent of APC/C.
- Utilized proteasome inhibitors to examine the reversibility of BRCA1-dependent degradation.
- Analyzed the impact of DNA damage on BRCA1-mediated protein degradation.
Main Results:
- Demonstrated that BRCA1 directly ubiquitinates G2/M cell cycle proteins, cyclin B and Cdc25C.
- Showed that BRCA1-induced degradation of cyclin B and Cdc25C is proteasome-dependent and APC/C-independent.
- Observed that this degradation is enhanced upon DNA damage.
- Found that proteasome inhibitors can reverse the BRCA1-mediated degradation of these proteins.
Conclusions:
- BRCA1 E3 ligase activity targets cyclin B and Cdc25C for accelerated degradation, preventing their accumulation.
- This mechanism provides insight into how BRCA1 regulates the G2/M cell cycle checkpoint.
- BRCA1's role in degrading key cell cycle proteins is vital for maintaining genomic stability and tumor suppression.
Related Concept Videos
Anaphase Promoting Complex
Anaphase Promoting Complex
Negative Regulator Molecules
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

